Efficacy and safety of antiviral treatments for symptomatic COVID-19 outpatients: network meta-analysis and budget impact analysis

Efficacy and safety of antiviral treatments for symptomatic COVID-19 outpatients: network meta-analysis and budget impact analysis

IntroductionRemdesivir (RDV) and nirmatrelvir/ritonavir (NRM/RTV) are two antiviral agents for treating outpatient adults with mild to moderate symptomatic COVID-19 at high risk of developing a severe disease. The review objectives are to compare the efficacy and safety of these antivirals based on...

Full description

Saved in:
Bibliographic Details
Main Authors: Giacomo Berti, Daniele Mengato, Honoria Ocagli, Gianmarco Chinellato, Maria Mazzitelli, Anna Maria Cattelan, Ileana Baldi, Francesca Venturini
Format: Article
Language:English
Published: Frontiers Media S.A. 2025-04-01
Series:Frontiers in Pharmacology
Subjects:
COVID-19
remdesivir
nirmatrelvir-ritonavir
network meta-analysis
outpatient
cost-analysis
Online Access:https://www.frontiersin.org/articles/10.3389/fphar.2025.1537018/full
Tags: Add Tag
No Tags, Be the first to tag this record!

Internet

https://www.frontiersin.org/articles/10.3389/fphar.2025.1537018/full

Similar Items